Health Sciences Group(OTC) HESG

Current Price$0.00

Market Cap$18.70K

Since IPO (2001)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Health Sciences Group last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-24

Health Sciences Group stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-07-17
1 month	+0%	USD 0.00	2026-06-22
3 month	+0%	USD 0.00	2026-04-23
Year to date	+0%	USD 0.00	2025-12-30
1 year	+0%	USD 0.00	2025-07-24
3 year	+0%	USD 0.00	2023-07-20
5 year	-99.5%	USD 0.00	2021-07-23
Since inception	-100%	USD 1.07	2001-08-03

Health Sciences Group Financials at a Glance

Market Cap

$18.70K

Revenue (TTM)

$69.31K

Net Income (TTM)

-$3.76M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

32.05 (High)

Dividend

$0.00

Beta (Volatility)

32.05 (High)

Price

$0.00

Volume

2,000,000

Open

$0.00

Price

$0.00

Volume

2,000,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 27, 2024

Dividend

$0.00

Beta (Volatility)

32.05 (High)

Price

$0.00

Volume

2,000,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 27, 2024

HESG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Health Sciences Group

Health Sciences Group, Inc. specializes in providing a diverse range of ingredients and finished products for the nutritional supplement and functional food and beverage sectors. The company is known for innovative products like Shugr, a calorie-free sugar alternative, and Sequesterol Advance Cardio Formula, designed to support cardiovascular health.

Products and Services

Shugr: A calorie-free sugar alternative with baking properties
Sequesterol Advance Cardio Formula: Supports cardiovascular well-being
Aplevia: An antioxidant derived from apple peels

Growth Outlook

Expansion into major retail chains and pharmacies enhances market reach
Innovative product development aligns with health trends
Increasing consumer demand for functional foods supports growth potential

Financial Highlights

Recent quarterly revenue of 4,943, showing a focus on product sales
Trailing twelve months (TTM) gross profit margin at 7.04%
Current ratio of 0.31 indicates liquidity challenges

Health Sciences Group, Inc. operates within the biotechnology industry, focusing on health-oriented products that cater to a growing consumer base. The company has established a presence in the market through its innovative offerings, which are well-positioned to meet the increasing demand for healthier alternatives. Despite facing liquidity challenges, the recent revenue figures indicate a commitment to improving sales performance. The strategic focus on expanding distribution channels and product innovation may provide a pathway for future growth, making it a noteworthy consideration for potential investors.

AI Generated • Jul 25, 2026

Industry

Food and Staples Retailing

Sector

Consumer Staples

Headquarters

Newport Beach, CA 92660, US

HESG Financials

Key Financial Metrics (TTM)

Gross Margin

7.04%

Operating Margin

-15.20%

Net Income Margin

-15.20%

Return on Equity

2.53%

Return on Capital

-5.95%

Return on Assets

-5.28%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$18.70K

Shares Outstanding

18.71B

Volume

2.00M

Avg. Volume

417.75K

Financials (TTM)

Gross Profit

$17.74K

Operating Income

-$2.43M

EBITDA

-$220.32K

Operating Cash Flow

-$184.13K

Capital Expenditure

$0.00

Free Cash Flow

-$544.13K

Cash & ST Invst.

$1.71K

Total Debt

$407.00K

Health Sciences Group Performance Analysis

Health Sciences Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2005-12-31	87.8%
Q1	2006-03-31	-44.0%
Q2	2006-06-30	-62.7%
Q3	2006-09-30	-35.0%

Health Sciences Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2005-12-31	101.0%
Q1	2006-03-31	-6766.7%
Q2	2006-06-30	33.3%
Q3	2006-09-30	25.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2006YOY CHG

Revenue

$4.94K

-74.5%

Gross Profit

$1.73K

-84.1%

Gross Margin

34.94%

N/A

Market Cap

$18.70K

N/A

Market Cap/Employee

$9.35K

N/A

Employees

N/A

Net Income

-$950.00K

+53.9%

EBITDA

-$506.00K

+75.6%

Quarterly Fundamentals

Name

Q3 2006YOY CHG

Total Cash

$1.71K

-99.4%

Total Debt

$407.00K

-24.9%

Accounts Receivable

$5.11K

-67.5%

Inventory

$53.87K

+74.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$407.00K

-24.9%

Return on Assets

-5.28%

N/A

Return on Invested Capital

-9.14%

N/A

Free Cash Flow

-$46.89K

+94.7%

Operating Cash Flow

-$46.89K

+94.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IONMAssure Holdings Corp.

IONMAssure Holdings Corp.$0.00+0.00%

VGLSSB Technology Holdings Inc.

VGLSSB Technology Holdings Inc.$0.22+0.00%

AGTXAgentix Corp.

AGTXAgentix Corp.$0.02+0.00%

EVIOEVIO, Inc.

EVIOEVIO, Inc.$0.00+0.00%

NBCONeon Bloom, Inc.

NBCONeon Bloom, Inc.$0.01+0.00%

AAGHAmerica Great Health

AAGHAmerica Great Health$0.00+0.00%

GRTXGalera Therapeutics, Inc.

GRTXGalera Therapeutics, Inc.$17.50+7.64%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.00-0.03%

STAKStak

STAKStak$9.27+6.02%

Questions About HESG

What is the current price of Health Sciences Group?

Health Sciences Group is trading at $0.00 per share.

What is the 52-week range for Health Sciences Group?

Over the past 52 weeks, Health Sciences Group has traded between $0.00 and $0.00.

How much debt does Health Sciences Group have?

Health Sciences Group total debt is unavailable.

How much cash does Health Sciences Group have on hand?

Health Sciences Group does not have cash on hand data available.

What is Health Sciences Group’s dividend yield?

Health Sciences Group does not currently have a dividend yield.

Health Sciences Group(OTC) HESG

Health Sciences Group Financials at a Glance

HESG News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Health Sciences Group

HESG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Health Sciences Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HESG

What is the current price of Health Sciences Group?

What is the 52-week range for Health Sciences Group?

How much debt does Health Sciences Group have?

How much cash does Health Sciences Group have on hand?

What is Health Sciences Group’s dividend yield?

Premium Investing Services